Position in NVAX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$276,976
+$16,847 QoQ
Shares Held
29,403
-8.0% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#121
of 263 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VARCOV Co. holds $10,399,067 across 30 Biotechnology names. NVAX ranks #20 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SMMT |
Summit Therapeutics Inc.
|
63,957 | $931,853 | |
| 2 | TARS |
Tarsus Pharmaceuticals, Inc.
|
13,057 | $821,807 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,018 | $546,615 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
13,926 | $543,253 | |
| 5 | RAPP |
Rapport Therapeutics, Inc.
|
12,895 | $537,334 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
5,390 | $427,373 | |
| 7 | SRRK |
Scholar Rock Holding Corp
|
7,530 | $414,150 | |
| 8 | CELC |
Celcuity Inc.
|
3,732 | $390,441 |
All Filings in NVAX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $276,976 | 29,403 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $260,129 | 31,957 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $262,510 | 39,064 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||